Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/prp2.829 http://scihub22266oqcxt.onion/10.1002/prp2.829 34278747!8287009!34278747     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Pharmacol+Res+Perspect 2021 ; 9 (4): e00829 Nephropedia Template TP {{tp|p=34278747|t=2021. An overview of diagnosis and management of drug-induced hypomagnesemia |pdf=|usr=}}{{34278747}} gab.com Text An overview of diagnosis and management of drug-induced hypomagnesemia JO: Pharmacol Res Perspect http://www.kidney.de/pget.php?&tw=1&pmid=34278747 #FOAvip Magnesium (Mg) is commonly addressed as the "forgotten ion" in medicine. Nonetheless, hypomagnesemia should be suspected in clinical practice in patients with relevant symptomatology and also be considered a predisposing factor for the development of other electrolyte disturbances. Furthermore, chronic hypomagnesemia has been associated with diabetes mellitus and cardiovascular disease. Hypomagnesemia as a consequence of drug therapy is relatively common, with the list of drugs inducing low serum Mg levels expanding. Culprit medications linked to hypomagnesemia include antibiotics (e.g. aminoglycosides, amphotericin B), diuretics, antineoplastic drugs (cisplatin and cetuximab), calcineurin inhibitors, and proton pump inhibitors. In recent years, the mechanisms of drug-induced hypomagnesemia have been unraveled through the discovery of key Mg transporters in the gut and kidney. This narrative review of available literature focuses on the pathogenetic mechanisms underlying drug-induced hypomagnesemia in order to increase the insight of clinicians toward early diagnosis and effective management. Twit Text FOAVip An overview of diagnosis and management of drug-induced hypomagnesemia ????Pharmacol Res Perspect http://www.kidney.de/pget.php?&tw=1&pmid=34278747 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34278747 #FOAvip English Wikipedia <ref>{{Cite pmid|34278747}}</ref> An overview of diagnosis and management of drug-induced hypomagnesemia #MMPMID34278747 Liamis G; Hoorn EJ; Florentin M; Milionis H Pharmacol Res Perspect 2021[Aug]; 9 (4): e00829 PMID34278747show ga Magnesium (Mg) is commonly addressed as the "forgotten ion" in medicine. Nonetheless, hypomagnesemia should be suspected in clinical practice in patients with relevant symptomatology and also be considered a predisposing factor for the development of other electrolyte disturbances. Furthermore, chronic hypomagnesemia has been associated with diabetes mellitus and cardiovascular disease. Hypomagnesemia as a consequence of drug therapy is relatively common, with the list of drugs inducing low serum Mg levels expanding. Culprit medications linked to hypomagnesemia include antibiotics (e.g. aminoglycosides, amphotericin B), diuretics, antineoplastic drugs (cisplatin and cetuximab), calcineurin inhibitors, and proton pump inhibitors. In recent years, the mechanisms of drug-induced hypomagnesemia have been unraveled through the discovery of key Mg transporters in the gut and kidney. This narrative review of available literature focuses on the pathogenetic mechanisms underlying drug-induced hypomagnesemia in order to increase the insight of clinicians toward early diagnosis and effective management. |*Drug-Related Side Effects and Adverse Reactions[MESH] |Animals[MESH] |Humans[MESH] |Magnesium Deficiency/blood/*etiology[MESH]An overview of diagnosis and management of drug-induced hypomagnesemia(epmc).pdf DeepDyve Pubget Overpricing